Lung cancer metastatic

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Checkpoint inhibitor (PD-1) 1 substance
Taxane 1 substance
Phase II/III: 1 Phase I (First in Human): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II/III

1 trial
  • IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic
    PACLITAXEL ALBUMIN-BOUND
    2025-522084-15-00 1 country n=36
    Pending

Phase I (First in Human)

1 trial
  • Achilles Therapeutics UK Limited Commercial
    ATL001; PEMBROLIZUMAB
    2024-513060-26-00 3 countries 2021 n=24
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Achilles Therapeutics UK Limited Commercial 1 Phase I (First in Human) 0
IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic 1 Phase II/III 0
New trials by year
2021
1
← All indication landscapes